よむ、つかう、まなぶ。
新型コロナウイルス感染症（COVID-19）診療の手引き・第7.2版 (26 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00332.html |
| 出典情報 | 「新型コロナウイルス感染症（COVID－19）診療の手引き・第7.1版」の周知について（5／9付 事務連絡）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
●新型コロナウイルス感染症（COVID-19） 診療の手引き・第 7.2 版 ●２ 臨床像
・Bellino S, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics 2020.
・Carfì A, et al. Persistent symptoms in patients after acute COVID-19. JAMA 2020.
・Carole H, et al. Attributes and predictors of long COVID. Nat Med 2021.
・Cevik M, et al. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 2020.
・Covid Data Tracker Weekly Review, Interpretive Summary for January 7, 2022.
・Feldstein LR. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020.
・Fukuda S, et al. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine
profile. Modern Rheumatology Case Reports 2021.
・Gandhi RT, et al. Mild and moderate Covid-19. N Engl J Med 2020.
・Gupta A, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020.
・Halfmann PJ, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 2022.
・Hayakawa S, et al. Covid-19 pandemic and pregnancy. J Obstet Gynaecol Res 2020.
・Hayakawa S, et al. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res 2021.
・Hoenigl M, et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet
Microb 2022.
・Horiuchi H, et al. COVID-19-related thrombosis in Japan: Final report of a questionnaire-based survey in 2020. J
Atheroscler Thromb 2021.
・Hou YJ, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 2020.
・Kanegaye JT, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009.
・Koehler P, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM
consensus criteria for research and clinical guidance. Lancet Infect Dis 2021.
・Komine-Aizawa S, et al. Placental barrier against COVID-19. Placenta 2020.
・Lansbury L, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020.
・Made CI, et al. Presence of genetic variants among young men with severe COVID-19. JAMA 2020.
・Matsunaga N, et al. Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19
REGISTRY JAPAN. Clin Infect Dis 2020.
・Mi SH, et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul. Emerg Infect Dis
2020.
・Miller E, et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults
in England. J Infect 2021.
・Miyazato Y, et al. Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020.
・Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med 2021.
・Oxley TJ, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020.
・Patel A, et al. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India. Emerg Infect Dis
2021．
・Prattes J, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a
multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021.
・Riphagen S, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020.
・Sakurai A, et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med 2020.
・Salim SH, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ 2020.
・Saurabh R, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
Infection. JAMA 2020.
・Shoji K, et al. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the
emergence of Delta variant of concern in Japan. J Infect Chemother 2022.
・Sudre CH, et al. Attributes and predictors of long COVID-19. Nat Med 2021.
・Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Takasago S, et al. Case report: Changes in cytokine kinetics during the course of disease in a Japanese patient with
multisystem inflammatory syndrome in children. Front Pediatr 2021.
・Takashita E, et al. Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant. N Engl J Med 2022.
・Takazono T, et al. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory
Society. ERJ Open Res 2021.
・Uchida M, et al: Multisystem inflammatory syndrome in children ― A new syndrome complicated with acute heart failure
following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection ―. Circ J 2021.
・Verdoni L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an
observational cohort study. Lancet 2020.
・Wei SQ, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021.
・WHO. COVID-19 Clinical management Living guidance. 23 Nov 2021.
・Wichmann D, et al. Autopsy findings and venous thromboembolism in patients with Covid-19. Ann Intern Med 2020.
・Wu Z, et al. Characteristics of and important lessons from the coronavirus disease 2019（COVID-19）outbreak in China :
Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Yasuhara J, et al. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and metaanalysis. Pediatric Pulmonology 2020.
・Zambrano LD, et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed
SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020. MMWR 2020．
・Zhang Q, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020.
26
・Bellino S, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics 2020.
・Carfì A, et al. Persistent symptoms in patients after acute COVID-19. JAMA 2020.
・Carole H, et al. Attributes and predictors of long COVID. Nat Med 2021.
・Cevik M, et al. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 2020.
・Covid Data Tracker Weekly Review, Interpretive Summary for January 7, 2022.
・Feldstein LR. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020.
・Fukuda S, et al. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine
profile. Modern Rheumatology Case Reports 2021.
・Gandhi RT, et al. Mild and moderate Covid-19. N Engl J Med 2020.
・Gupta A, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020.
・Halfmann PJ, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 2022.
・Hayakawa S, et al. Covid-19 pandemic and pregnancy. J Obstet Gynaecol Res 2020.
・Hayakawa S, et al. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res 2021.
・Hoenigl M, et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet
Microb 2022.
・Horiuchi H, et al. COVID-19-related thrombosis in Japan: Final report of a questionnaire-based survey in 2020. J
Atheroscler Thromb 2021.
・Hou YJ, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 2020.
・Kanegaye JT, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009.
・Koehler P, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM
consensus criteria for research and clinical guidance. Lancet Infect Dis 2021.
・Komine-Aizawa S, et al. Placental barrier against COVID-19. Placenta 2020.
・Lansbury L, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020.
・Made CI, et al. Presence of genetic variants among young men with severe COVID-19. JAMA 2020.
・Matsunaga N, et al. Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19
REGISTRY JAPAN. Clin Infect Dis 2020.
・Mi SH, et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul. Emerg Infect Dis
2020.
・Miller E, et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults
in England. J Infect 2021.
・Miyazato Y, et al. Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020.
・Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med 2021.
・Oxley TJ, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020.
・Patel A, et al. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India. Emerg Infect Dis
2021．
・Prattes J, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a
multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021.
・Riphagen S, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020.
・Sakurai A, et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med 2020.
・Salim SH, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ 2020.
・Saurabh R, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
Infection. JAMA 2020.
・Shoji K, et al. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the
emergence of Delta variant of concern in Japan. J Infect Chemother 2022.
・Sudre CH, et al. Attributes and predictors of long COVID-19. Nat Med 2021.
・Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Takasago S, et al. Case report: Changes in cytokine kinetics during the course of disease in a Japanese patient with
multisystem inflammatory syndrome in children. Front Pediatr 2021.
・Takashita E, et al. Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant. N Engl J Med 2022.
・Takazono T, et al. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory
Society. ERJ Open Res 2021.
・Uchida M, et al: Multisystem inflammatory syndrome in children ― A new syndrome complicated with acute heart failure
following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection ―. Circ J 2021.
・Verdoni L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an
observational cohort study. Lancet 2020.
・Wei SQ, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021.
・WHO. COVID-19 Clinical management Living guidance. 23 Nov 2021.
・Wichmann D, et al. Autopsy findings and venous thromboembolism in patients with Covid-19. Ann Intern Med 2020.
・Wu Z, et al. Characteristics of and important lessons from the coronavirus disease 2019（COVID-19）outbreak in China :
Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Yasuhara J, et al. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and metaanalysis. Pediatric Pulmonology 2020.
・Zambrano LD, et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed
SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020. MMWR 2020．
・Zhang Q, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020.
26